ADAPTING PHARMACOECONOMIC DATA OF ANALYSES FROM OVERSEAS FOR USE IN DECISIONS IN MIDDLE INCOME COUNTRIES
Author(s)
Nathorn Chaiyakunapruk, PhD, Monash University Malaysia, Selangor, Malaysia; Michael F. Drummond, MCom, DPhil, University of York, Heslington, York, UK; Jasmine Pwu, PhD, National Taiwan University, Taipei, Taiwan; Bong-Min Yang, PhD, Seoul National University, Seoul, South Korea
Presentation Documents
PURPOSE: Decision makers in middle income countries are increasingly using economic evaluations in pricing and reimbursement decisions for pharmaceuticals and other technologies. However, whilst many of these jurisdictions have local submission guidelines and local expertise, the studies submitted by technology manufacturers often use economic models developed elsewhere and elements of data from other countries. The purpose of this workshop is to discuss the challenges faced by decision makers in transferring data and analyses from other jurisdictions and the methods available.
DESCRIPTION: In this workshop the challenges faced by decision makers in transferring data and analyses from other jurisdictions will be discussed. The workshop will draw on the results of an interview survey of representatives of decision making bodies in 12 jurisdictions in Asia, Central and Eastern Europe, and Latin America that have had at least one year’s experience of using economic evaluations. The discussion leaders will discuss the results of the survey and will present their own perspectives on the main obstacles in using data or analyses from other countries and the challenges in conducting local analyses in the Asia-Pacific region. Participants in the workshop will have the opportunity to share their own experiences in transferring foreign data or analyses.
Conference/Value in Health Info
2016-09, ISPOR Asia Pacific 2016, Singapore
Code
W6
Topic
Economic Evaluation, Health Technology Assessment